ERN1 and stroke disorder: Injection of rhMANF 2 h post-stroke reduced the levels of XBP1s, GRP78, and p-IRE1, and enhanced neuron numbers and behavioral recovery while inhibiting caspase 3 (Yang et al., 2014).